Cartesian Therapeutics Stock (RNAC)
Track Cartesian Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
RNAC
Cartesian Therapeutics
healthcare
$7.04
▼ -1.84 (-20.98%) past year
Market Cap
$189.51M
P/E Ratio
—
1Y Return
-20.98%
EPS (TTM)
-$5.80
Read the latest TheStreet Pro articles mentioning Cartesian Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning RNAC yet.
Daily Diary Mentions
0 mentionsNo diary mentions for RNAC yet.